Xeris Pharmaceuticals Inc (XERS) — Net Asset Quality Index
Xeris Pharmaceuticals Inc (XERS) has a Net Asset Quality Index of -2.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $411.90 Million minus total liabilities of $421.64 Million yields net assets of $-9.73 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check XERS cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Xeris Pharmaceuticals Inc Net Asset Quality Index Over Time (2016–2025)
This chart shows how Xeris Pharmaceuticals Inc's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the index stands at -2.4%, representing net assets of $-9.73 Million against total assets of $411.90 Million USD. See XERS net assets for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Xeris Pharmaceuticals Inc (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Xeris Pharmaceuticals Inc from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Xeris Pharmaceuticals Inc stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 3.6% | $13.69 Million | $383.53 Million | $369.84 Million | ▲ +12.7 pp |
| 2024 | -9.2% | $-29.61 Million | $323.06 Million | $352.68 Million | ▼ -7.1 pp |
| 2023 | -2.1% | $-6.78 Million | $322.60 Million | $329.38 Million | ▼ -15.2 pp |
| 2022 | 13.1% | $45.19 Million | $344.52 Million | $299.33 Million | ▼ -18.2 pp |
| 2021 | 31.3% | $95.23 Million | $304.36 Million | $209.13 Million | ▲ +18.0 pp |
| 2020 | 13.2% | $14.44 Million | $108.99 Million | $94.55 Million | ▲ +0.0 pp |
| 2019 | 13.2% | $14.44 Million | $108.99 Million | $94.55 Million | ▼ -49.6 pp |
| 2018 | 62.8% | $75.41 Million | $120.03 Million | $44.62 Million | ▲ +191.3 pp |
| 2017 | -128.5% | $-57.83 Million | $45.00 Million | $102.83 Million | ▼ -33.3 pp |
| 2016 | -95.2% | $-31.93 Million | $33.53 Million | $65.47 Million | — |